T80.39XD Other ABO incompatibility reaction due to transfusion of blood or blood products, subsequent encounter

Name of the Condition

• Other ABO incompatibility reaction due to transfusion of blood or blood products, subsequent encounter.

Summary

This condition describes an adverse immune reaction resulting from the transfusion of blood or blood products with incompatible ABO antigens, occurring during a subsequent encounter. It is a serious complication that can lead to hemolysis, organ dysfunction, and systemic effects. The reaction occurs when pre-existing antibodies in the recipient target antigens on the transfused blood cells, triggering an immune response. This code is used for encounters after the initial reaction has been treated.

Causes

ABO incompatibility reactions are caused by the transfusion of blood or blood products that do not match the recipient's ABO blood type. This mismatch leads to the destruction of transfused red blood cells by the recipient's antibodies, resulting in hemolysis. Errors in blood typing, crossmatching, or administration can contribute to this complication. The subsequent encounter code applies when the patient is seen for ongoing management or sequelae of the initial reaction.

Risk Factors

• Transfusion of blood products without proper ABO typing or crossmatching
• Emergency transfusions where typing may be delayed
• Human error in blood product labeling or administration
• Use of pooled plasma products with mixed ABO types
• Transfusion of platelets or plasma from donors with incompatible ABO antigens

Symptoms

• Fever, chills, or rigors
• Flank pain or back pain
• Hemoglobinuria (dark urine)
• Hypotension or tachycardia
• Dyspnea or respiratory distress
• Jaundice or pallor
• Nausea, vomiting, or abdominal pain
• Renal dysfunction or oliguria

Diagnosis

Diagnosis involves clinical evaluation of symptoms, laboratory tests to confirm hemolysis (e.g., elevated bilirubin, decreased haptoglobin, hemoglobinuria), and verification of blood product compatibility. ABO typing and crossmatching of the transfused product and recipient are essential. Imaging or additional tests may assess organ damage, such as renal function or pulmonary status. Documentation must support the subsequent encounter context.

Treatment Options

Treatment focuses on managing hemolysis, supporting organ function, and preventing further complications. Interventions may include discontinuing the transfusion, administering fluids, and using medications to address symptoms (e.g., antipyretics, vasopressors). Renal protection (e.g., maintaining urine output) and monitoring for coagulopathy are critical. In severe cases, dialysis or other organ support may be required.

Prognosis and Follow-Up

Prognosis depends on the severity of the reaction and promptness of treatment. Most patients recover with appropriate management, but severe cases can lead to long-term organ damage. Follow-up includes monitoring for delayed complications (e.g., renal impairment) and ensuring no further incompatible transfusions occur. Regular lab tests and clinical assessments guide recovery.

Complications

• Acute kidney injury or renal failure
• Disseminated intravascular coagulation (DIC)
• Shock or multi-organ dysfunction
• Pulmonary edema or respiratory failure
• Long-term renal or hepatic impairment

Lifestyle & Prevention

Prevention relies on strict adherence to blood typing, crossmatching, and verification protocols before transfusion. Double-checking labels and using barcode systems reduce human error. Patients with known antibodies or sensitivities should have clear documentation. Avoiding unnecessary transfusions and using compatible products minimize risk.

When to Seek Professional Help

Seek immediate medical attention if symptoms of a transfusion reaction occur, such as fever, chills, pain, or changes in urine color. For subsequent encounters, consult a healthcare provider if new or worsening symptoms (e.g., shortness of breath, swelling, or reduced urine output) develop. Ongoing monitoring is essential for those with prior reactions.

Tips for Medical Coders

Use this code for encounters related to the management of an ABO incompatibility reaction due to blood or blood product transfusion, where the encounter is subsequent to the initial reaction. Document the clinical context, including the nature of the follow-up (e.g., monitoring, treatment of sequelae) and any relevant lab or imaging results. Ensure the code aligns with the timing of the encounter and the specificity of the reaction (other ABO incompatibility).